Objectives: The impact of extrapulmonary organ dysfunction, independent from sepsis and lung injury severity, on outcomes in pediatric acute respiratory failure is unclear. We sought to determine the frequency, timing, and risk factors for extrapulmonary organ dysfunction and the independent association of multiple organ dysfunction syndrome with outcomes in pediatric acute respiratory failure. Measurements and Main Results: Organ dysfunction was defined using criteria published for pediatric sepsis. Multiple organ dysfunction syndrome was defined as respiratory dysfunction one or more extrapulmonary organ dysfunctions. We used multivariable logistic regression to identify risk factors for multiple organ dysfunction syndrome, and logistic or proportional hazards regression to compare clinical outcomes. All analyses accounted for PICU as a cluster variable. Overall, 73% exhibited extrapulmonary organ dysfunction, including 1,547 (63%) with concurrent multiple organ dysfunction syndrome defined by onset on day 0/1 and 244 (10%) with new multiple organ dysfunction syndrome with onset on day 2 or later. Most patients (93%) with indirect lung injury from sepsis presented with concurrent multiple organ dysfunction syndrome, whereas patients with direct lung injury had both concurrent (56%) and new (12%) multiple organ dysfunction syndrome. Risk factors for concurrent multiple organ dysfunction syndrome included older age, illness severity, sepsis, cancer, and moderate/severe lung injury. Risk factors for new multiple organ dysfunction syndrome were moderate/severe lung injury and neuromuscular blockade. Both concurrent and new multiple organ dysfunction syndrome were associated with 90-day in-hospital mortality (concurrent: adjusted odds ratio, 6.54; 95% CI, 3.00-14.25 and new: adjusted odds ratio, 3.21; 95% CI, 1.48-6.93) after adjusting for sepsis, moderate/severe lung injury, and other baseline characteristics. Conclusions: Extrapulmonary organ dysfunction was common, generally occurred concurrent with respiratory dysfunction (especially
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As in other critical illnesses, multiple organ dysfunction syndrome (MODS) is often present at death in mechanically ventilated children (3-5, 7, 9, 10, 13) . However, the timing and impact of extrapulmonary organ dysfunction and MODS on the outcomes of children with acute respiratory failure is not clear. An important challenge has been to separate the independent role of MODS on outcome from the impact of either sepsis or PARDS severity, since extrapulmonary organ dysfunction is more likely to be present in these two scenarios than in other cases of acute respiratory failure (7) . Prior studies of extrapulmonary organ dysfunction in children with acute respiratory failure have been limited by small sample size (< 350 patients) and have predominantly focused on PARDS (3-5, 7, 9, 10, 13) . In addition, most prior pediatric studies have relied on the 1994 American European Consensus Conference adult definitions of ARDS, whereas the Pediatric Acute Lung Injury Consensus Conference (PALICC) published updated criteria for PARDS in 2015 (14, 15) .
The Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) cluster-randomized trial compared a sedation protocol to usual care in 2,449 children mechanically ventilated for acute respiratory failure (ClinicalTrials.gov NCT00814099) (16) . RESTORE provides a large, contemporary, prospectively collected dataset with extensive quality oversight that included daily review of extrapulmonary organ dysfunction. Through a secondary analysis of the RESTORE dataset, our objectives were to determine 1) the frequency, timing, and risk factors for extrapulmonary organ dysfunction and 2) the impact of MODS, independent from sepsis etiology and moderate/severe PARDS, on clinical outcomes for a broad spectrum of children with respiratory failure requiring invasive mechanical ventilation.
METHODS

Study Design
RESTORE was a prospective, cluster-randomized clinical trial conducted between 2009 and 2013 in 31 U.S. PICUs (16) . The aim of RESTORE was to test whether a nurse-implemented, goal-directed sedation protocol could reduce the duration of invasive mechanical ventilation for children with acute respiratory failure compared with usual care. All care, other than the sedation protocol at intervention PICUs, was at the discretion of the clinical team. Details of the RESTORE methodology and primary results have been published (16) .
Population
We included all patients enrolled in the RESTORE trial. Patients were 2 weeks to 17 years old with new invasive mechanical ventilation for acute airways and/or parenchymal lung disease. Excluded were patients expected to be extubated within 24 hours, transferred from an outside PICU with sedative exposure greater than 24 hours, or with unrepaired cyanotic heart disease, primary pulmonary hypertension, chronic ventilator-dependence, and neuromuscular respiratory failure. Written informed consent was obtained from the legal guardian of each patient.
Data Collection
Patient characteristics included demographic data, baseline Pediatric Cerebral Performance Category and Pediatric Overall Performance Category (17) , Pediatric Risk of Mortality (PRISM) III-12 score (18) , primary etiology of lung disease, and comorbid conditions. Acute respiratory failure due to sepsis was defined as a nonpulmonary systemic infection. Although pneumonia is often included as sepsis, for the purposes of differentiating direct from indirect etiologies of lung disease in this study, pneumonia and extrapulmonary sepsis were considered separately. PARDS severity on day 0/1 was defined using the 2015 PALICC criteria. (15) . Study day 0/1 referred to the first two calendar days (up to 48 hr) of mechanical ventilation (16) .
Respiratory dysfunction was defined as receipt of invasive mechanical ventilation. Extrapulmonary organ dysfunction was defined using modified criteria set by the International Pediatric Sepsis Consensus Conference (eTable 1, Supplemental Digital Content 1, http://links.lww.com/PCC/A382) (19) . Patients were assessed daily for organ dysfunction while in the PICU. Since all patients had respiratory dysfunction as part of the RESTORE inclusion criteria, MODS was defined as at least one additional extrapulmonary organ dysfunction. We defined "concurrent MODS" as extrapulmonary organ dysfunction present on study day 0/1 (i.e., concurrent with onset of respiratory failure) and "new MODS" as extrapulmonary organ dysfunction that developed on study day 2 or later (20) .
Outcomes
The primary outcome for this study was development of MODS, trichotomized as respiratory dysfunction only, concurrent MODS, or new MODS. Clinical outcomes compared between MODS groups were duration of mechanical ventilation, PICU and hospital length of stay (LOS) in survivors (censored at study day 90), in-hospital mortality at 28 and 90 days, and proportion of patients not discharged home alive by day 90. For duration of mechanical ventilation, patients were assigned 28 days if they remained intubated, were transferred, or died prior to day 28 without being extubated for more than 24 hours. Therefore, this outcome is equivalent to ventilatorfree days (21) . Notably, there was no evidence in the RESTORE primary analysis that the sedation protocol intervention had a significant impact on duration of mechanical ventilation, LOS, or mortality (16) .
Analysis
We used logistic regression to assess the effects of patient characteristics to predict 1) concurrent MODS versus all other patients and 2) new MODS versus respiratory dysfunction only. We graphically represented time to onset of first extrapulmonary organ dysfunction, assigning greater than 28 days to patients with respiratory dysfunction only, and compared between etiologies using the log-rank test. Maximum number of organ dysfunctions was compared between those with concurrent and new MODS using cumulative logit regression. The time course of respiratory and extrapulmonary organ dysfunction was analyzed graphically by plotting the proportion of patients with organ dysfunction among all patients remaining in the PICU on each study day and by calculating Spearman correlations between this proportion and study day.
We used stepwise multivariable logistic regression to identify independent risk factors for concurrent or new MODS from the patient characteristics listed in Table 1 , using p value of less than 0.05 for a covariate to enter and stay in each model. For risk of concurrent or new MODS, we also a priori planned to adjust for age group, baseline functional impairment, and PRISM III-12 scores, even if these covariates would have otherwise been excluded through stepwise modeling. Next, clinical outcomes were compared between MODS groups using logistic or proportional hazards regression as appropriate. We then used multivariable modeling to further evaluate the independent effect of MODS on outcomes after controlling for the following covariates: age group, baseline functional impairment, PRISM III-12 score, sepsis etiology, and moderate/severe PARDS on day 0/1. Potential interactions between MODS and sepsis or PARDS were investigated as defined a priori. All regression analyses accounted for PICU as a cluster variable using generalized estimating equations. Analyses were performed using SAS (Version 9.4; SAS Institute, Cary, NC). Statistical significance was p value of less than 0.05.
RESULTS
Frequency and Timing of MODS
Of the 2,449 patients in the RESTORE trial, 1,791 (73%) developed MODS with at least one extrapulmonary organ dysfunction, including 1,547 (63%) who presented with concurrent MODS on day 0/1 of respiratory failure and 244 (10%) with new MODS initially developing between day 2 and 28. Characteristics for patients with respiratory dysfunction only, concurrent MODS, and new MODS are presented in Table 1 . Patients with concurrent MODS were older and more likely to have cancer and have sepsis as the etiology for respiratory failure, with higher PRISM III-12 scores and more severe initial lung disease. Patients with new MODS had similar initial illness severity and distribution of etiologies for respiratory failure as patients with respiratory dysfunction only. However, patients with new MODS exhibited a higher rate of moderate/severe PARDS compared with patients with respiratory dysfunction only. Cardiovascular (38%) and neurologic (37%) dysfunctions were the most common extrapulmonary organ dysfunctions on day 0/1, followed by hematologic (15%), hepatic (14%), and renal (5%). All extrapulmonary organ dysfunctions were more common in sepsis than other etiologies of respiratory failure (eTable 2, Supplemental Digital Content 2, http://links.lww. com/PCC/A383). However, the types of extrapulmonary organ dysfunction were similar across etiologies with the exception that patients with sepsis and pneumonia had a higher proportion of hematologic dysfunction compared with those with bronchiolitis, asthma, or aspiration. Forty-three percent with MODS had a maximum of two organ dysfunctions (including respiratory) and 27% had three organ dysfunctions. Patients with concurrent MODS had a higher maximum number of organ dysfunctions compared with patients with new MODS (median 3 [interquartile range, 2-4] vs 2 [2] [3] ; p < 0.001).
Overall, 86% of patients with MODS exhibited their first day of extrapulmonary organ dysfunction on day 0/1 and 58% presented with their maximum number of organ dysfunctions on day 0/1. However, the timing of first extrapulmonary organ dysfunction differed by etiology of respiratory failure (logrank p < 0.001) ( Fig. 1) with shortest onset in sepsis and longest in bronchiolitis. Patients with indirect lung injury from sepsis were most likely to present with concurrent MODS, with 332 of 357 (93%) exhibiting MODS by day 0/1 of respiratory failure and only eight (2%) developing new MODS. In contrast, 1,023 (56%) of 1,839 patients with "direct" lung injury from pneumonia, bronchiolitis, asthma, and aspiration presented with concurrent MODS and 221 (12%) developed new MODS (Table 1) .
Extrapulmonary organ dysfunction decreased over the first 7 days to a plateau of 37%, then increased slightly for patients who remained in the PICU (Fig. 2A) . Most cardiovascular and neurologic dysfunctions were present on day 0/1, hematologic and hepatic dysfunctions increased over time (hematologic: Spearman r = 0.48, p = 0.01; hepatic: r = 0.78, p < 0.001), and renal dysfunction remained relatively constant (r = 0.24; p = 0.21) (Fig. 2B) .
Risk Factors for MODS
Independent risk factors for concurrent MODS included older age, higher baseline illness severity, sepsis etiology, cancer comorbidity, and moderate/severe PARDS on day 0/1 ( Table 2) . Baseline functional impairment and preexisting seizure disorder were independently associated with a decreased risk for concurrent MODS. The only independent risk factors for new MODS were moderate/severe PARDS on day 0/1 and use of neuromuscular blockade for entire (42) 165 (68) 2 yr to < 6 yr 100 (15) 283 (18) 35 (14) 6 yr to < 18 yr 108 (16) 614 (40) 44 (18) Female, n (%) 272 (41) 720 (47) 109 (45) (8) 135 (9) 17 (7) Aspiration pneumonia 41 (6) 93 (6) 15 (6) Other 46 (7) 192 (12) 15 (6) Past medical history, n (%) Prematurity (< 36 wk postmenstrual age)
113 (17) 208 (13) 48 (20 duration of days 0-2 (Table 2) . Notably, intervention group was not associated with either concurrent or new MODS in the multivariable models.
Impact of MODS on Clinical Outcomes
Of the 110 nonsurvivors by day 28, 103 (94%) exhibited concurrent MODS and two (2%) exhibited new MODS. Both moderate/severe PARDS on day 0/1 and MODS were independently associated with 90-day in-hospital mortality and discharge to home alive by day 90 ( 157 (24) 183 (12) 37 (15) Mild (OI, 4.0-7.9 or OSI, 5.0-7.4) 180 (27) 298 (19) 55 (23) Moderate (OI, 205 (31) 419 (27) 72 (30) Severe ( 
DISCUSSION
MODS occurred frequently in pediatric patients with a broad spectrum of acute respiratory failure requiring invasive mechanical ventilation, with nearly three-quarters exhibiting at least one extrapulmonary organ dysfunction. The majority of organ dysfunctions were present concurrent with the onset of respiratory failure, especially in patients with sepsis-induced indirect lung injury. In patients with direct lung injury, however, many also developed new MODS on day 2 or later. Moderate/severe PARDS was an independent risk factor for both concurrent and new MODS, whereas sepsis was a risk factor only for concurrent MODS. Nearly, all deaths occurred in patients with concurrent MODS though new MODS was associated with worse outcomes in the subset with less severe lung injury (i.e., at-risk and mild PARDS).
Our findings are consistent with smaller studies that have demonstrated an association of extrapulmonary organ dysfunction with increased risk of death in pediatric acute respiratory failure (3) (4) (5) 9) . Our data add to this body of literature by 1) confirming the common occurrence of extrapulmonary organ dysfunction in a larger and broader cohort of pediatric patients with acute respiratory failure, 2) bolstering the association of extrapulmonary organ dysfunction with outcomes beyond PICU mortality to include 90-day in-hospital mortality, mechanical ventilation duration, and LOS, and 3) differentiating between extrapulmonary organ dysfunction existing concurrent with or developing subsequent to the onset of Figure 1 . Time to first extrapulmonary organ dysfunction by etiology of respiratory failure. Time to onset of first extrapulmonary organ dysfunction differed according to etiology of acute respiratory failure (log-rank p < 0.001). Patients were removed from the number at-risk after the first day of meeting criteria for at least one extrapulmonary organ dysfunction. Patients who never developed extrapulmonary organ dysfunction were included through day 28, including those patients who left the hospital for whom it was presumed that no further organ dysfunction occurred beyond discharge. RAD = reactive airways disease. . Data for each day were calculated as the proportion of patients with the specified organ dysfunction among all patients remaining in the PICU on that day. All patients who remained in the PICU with organ dysfunction were included in the numerator irrespective of whether organ dysfunction developed on that day or a prior day but were removed from the numerator if organ dysfunction resolved. Patients were included in the denominator if they remained in the PICU on that day, irrespective of whether organ dysfunction continued or resolved.
Pediatric Critical Care Medicine www.pccmjournal.org 325 respiratory failure. Concurrent MODS present within 48 hours of initiation of invasive mechanical ventilation for acute respiratory failure was substantially more common than new MODS developing on day 2 or later. Patients with concurrent MODS also exhibited a greater overall number of extrapulmonary organ dysfunctions and had higher mortality than patients with new MODS.
Several independent risk factors were noted for concurrent MODS, most notably cancer and sepsis. Prior studies have consistently shown that extrapulmonary sepsis is the second or third most common cause of PARDS (3-5, 7, 9, 13, 22) . Sepsis is also responsible for a disproportionate number of deaths compared with causes of direct lung injury (3) (4) (5) 7) . It is likely that sepsis-induced respiratory failure shares pathobiologic mechanisms of extrapulmonary organ dysfunction in severe infection, such as microvascular thromboses and malperfusion. In contrast, new MODS was more common with direct lung injury, suggesting that primary hypoxemia and pulmonary biotrauma may precede-and perhaps even contribute to-later onset of extrapulmonary organ dysfunction in patients without sepsis, as suggested by Trachsel et al (7) . The association of moderate/severe PARDS, defined as a more severe oxygenation defect at higher ventilatory pressures, with development of new MODS supports such a link between severity of lung injury and progression of extrapulmonary organ dysfunction. The association of early neuromuscular blockade, most commonly used with severe, refractory hypoxemia, with new MODS further suggests that early oxygenation defects could be linked to evolving extrapulmonary organ dysfunction; however, we cannot differentiate this explanation from an alternative connection between pharmacologic neuromuscular blockade and new MODS. In contrast to smaller studies, we were also able to separate the independent impact of MODS on outcome from the effect of either sepsis or PARDS severity. The presence of extrapulmonary organ dysfunction was a strong independent risk factor for adverse outcomes after controlling for both sepsis and moderate/severe PARDS. This finding is consistent with reports that MODS is a more common cause of death than refractory hypoxemia in PARDS (3, 5, 7, 9, 10, 13) . The predominant early onset of MODS in our study further supports that, in most cases, MODS is not merely a reflection of the 7.6 (4.9-10.9) 10.7 (6.3-17.8) 12.7 (8.1-19.6 ) < 0.001 Hospital 12 (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) 17 19 (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) < 0.001
In-hospital mortality, n (%)
At 28 d 5 (< 1) 103 (7) 2 (< 1) < 0.001
At 90 d 5 (< 1) 143 (9) 7 ( (4) 317 (20) 33 (14) < 0.001 IQR = interquartile range, MODS = multiple organ dysfunction syndrome.
a p values for the comparison between multiple organ dysfunction syndrome groups were calculated using proportional hazards and logistic regression accounting for PICU as a cluster variable using generalized estimating equations for time-to-event and binary variables, respectively. immediate process of dying. A similar pattern of early extrapulmonary organ dysfunction was reported in a large prospective study of adult ARDS (22) . Together, these data suggest interventions beyond lung-based therapies that reverse hypoxemia as a solitary therapeutic strategy may be necessary to improve outcomes in PARDS. Reversing hypoxia and improving lung disease could prove inadequate to rescue patients from death if extrapulmonary organ dysfunction cannot be simultaneously managed. Indeed, numerous attempts to reverse hypoxemia have not consistently translated into beneficial patient outcomes (8, (23) (24) (25) (26) . In children, where extrapulmonary organ dysfunction is largely present at onset of acute respiratory failure, improved oxygenation should be tested alongside novel therapies that also target extrapulmonary organ injury. Our findings also support including extrapulmonary organ dysfunction in the risk-stratification scheme for PARDS. Existing criteria and most ARDS research focus on severity of hypoxemia in conjunction with ventilatory settings (5, 9, 13, (27) (28) (29) . However, data in this study and prior investigations demonstrate that extrapulmonary organ dysfunction is a strong risk factor for death independent from severity of hypoxemia or other respiratory criteria (3) (4) (5) . However, neither PALICC nor the Berlin conference included extrapulmonary organ dysfunction in their risk-stratification schemes (15, 30) . In pediatrics, this was despite the finding by a PALICC subcommittee that MODS "is the single most important independent clinical risk factor for mortality at the onset of ARDS" (31) .
There are several limitations to this study. First, only patients with informed consent for the parent trial were included. Fortunately, RESTORE achieved a 78.4% consent rate (16) , and the large sample size distributed across 31 sites likely mitigated selection bias in comparison to prior smaller studies. Second, patients with unrepaired cyanotic heart disease were excluded from RESTORE, though these patients are included in the updated PARDS definition. Third, we did not retain group assignment from the parent trial in our multivariable models to evaluate the impact of MODS on outcomes. However, the sedation protocol did not affect clinical outcomes (16) and was unlikely to differentially impact organ injury than sedation practices used at usual care sites. Fourth, published criteria were used to define organ dysfunction (19) , but several modifications were employed in the parent study. For example, patients with chronically abnormal organ dysfunction-defining laboratory variables (e.g., platelet count, creatinine) were not evaluated differently from patients with normal baseline values. However, any potential misclassification bias would have been toward the null by attributing chronic organ dysfunction to an acute process in some patients. The need to address inconsistent definitions for organ dysfunction in PARDS has been acknowledged (31) . Furthermore, while the optimal timing of OI/OSI to define PARDS is controversial (e.g., initial vs worst OI/OSI in the first 24 hr) (15), we used the worst available OI/OSI on day 0/1 as a risk factor for MODS and clinical outcomes. Fifth, we cannot determine if one contributing factor to the association of new MODS with longer LOS and duration of mechanical ventilation was that patients with prolonged respiratory failure had more time to develop extrapulmonary organ dysfunction. Finally, data indicating whether extrapulmonary organ dysfunction preceded study day 0/1 were not available. It is likely that some patients with concurrent MODS actually had acute organ dysfunction preceding respiratory failure. Furthermore, because testing for organ dysfunction was at the discretion of the clinician, some cases of mild organ dysfunction may have been missed.
CONCLUSIONS
Extrapulmonary organ dysfunction was common, generally occurred concurrent with respiratory failure (especially in sepsis), and was the largest independent risk factor for death and longer duration of mechanical ventilation and LOS in pediatric patients mechanically ventilated for acute respiratory failure. Future studies should consider extrapulmonary organ dysfunction as both a risk-stratification variable and a target for therapeutic intervention along with lung-supportive strategies.
